FIELD: organic synthesis.
SUBSTANCE: invention provides compounds of general formula I:
, where R1 represents -CO-Ra, -SO2-Rb, or aryl optionally substituted by lower alkoxy, wherein Ra represents cycloalkyl, cycloalkyl(lower)alkyl, cycloalkyloxy, aryl, aryloxy, aryl(lower)alkyl, aryl(lower)alkoxy, aryloxy(lower)alkyl, aryl-S-(lower)alkyl, aryl(lower)alkenyl, provided that aryl group can be optionally substituted by halogen, lower alkyl, hydroxy, nitro, cyano, lower alkoxy, phenyl, CF3, cyano(lower)alkyl, lower alkyl-C(O)NH, lower alkyl-CO, and lower alkyl-S; heteroaryl, heteroaryl(lower)alkyl, or heteroaryl(lower)alkoxy, provided that heteroaryl group is 5- or 6-membered ring or bicyclic aromatic group constituted by two 5- or 6-membered rings including 1-3 heteroatoms selected from oxygen, nitrogen, and sulfur and that heteroaryl group can be optionally substituted by lower alkoxy; Rb represents aryl, aryl(lower)alkyl, or heteroaryl, aryl group optionally substituted by halogen, cyano, or lower alkyl-C(O)NH; R2 and R3 represent hydrogen atoms; R4 representshydrogen or lower alkyl; R5 represents hydrogen, lower alkyl, cycloalkyl, benzodioxyl, or aryl optionally substituted by lower alkyl, halogen, lower alkoxy, hydroxy, or (lower)alkyl-C(O)O; n is 1 or 2; and pharmaceutically acceptable salts thereof and/or pharmaceutically acceptable esters thereof. Invention also provides a pharmaceutical composition exhibiting inhibitory activity with regard to cysteine proteases of the cathepsin family, which composition comprises compound of formula I, pharmaceutically acceptable recipient, and/or adjuvant.
EFFECT: increased choice of cysteine protease inhibitors.
34 cl, 1 tbl, 13 ex
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED DERIVATIVES OF CYCLOHEXANE | 2002 |
|
RU2288221C2 |
NEW DERIVATIVES OF HETEROCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION, METHOD FOR MODULATION OF AUTOIMMUNE DISEASES, METHOD FOR PREPARING THESE COMPOUNDS | 2000 |
|
RU2255937C2 |
DERIVATIVES OF HETEROARYL-SUBSTITUTED AMINOCYCLOHEXANE, METHOD FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2002 |
|
RU2286987C2 |
ARYL-CYCLOHEXYL-TETRAAZABENZO[e]AZULENES | 2011 |
|
RU2566759C2 |
CYCLOALKYLAMINE DERIVATIVES | 2005 |
|
RU2402526C2 |
HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS CATHEPSIN S TRANSPORTATION INHIBITORS | 2005 |
|
RU2424239C2 |
SPIROCYCLIC NITRILES AS PROTEASE INHIBITORS | 2007 |
|
RU2478620C2 |
DIPEPTIDE NITRILE INHIBITORS OF CATHEPSIN K | 2001 |
|
RU2265601C2 |
SPIROCYCLIC NITRILES AS PROTEASE INHIBITORS | 2012 |
|
RU2621695C2 |
DIPEPTIDE-NITRILE INHIBITORS OF CATHEPSIN K | 2001 |
|
RU2293732C2 |
Authors
Dates
2005-02-10—Published
2001-06-08—Filed